Details of the BTS
General Information of Binding Target of SBP (BTS) (ID: ST00106) | ||||||
---|---|---|---|---|---|---|
BTS Name |
Protein SET
|
|||||
Synonyms |
HLA-DR-associated protein II; Inhibitor of granzyme A-activated DNase; IGAAD; PHAPII; Phosphatase 2A inhibitor I2PP2A; I-2PP2A; Template-activating factor I; TAF-I
|
|||||
BTS Type |
Protein
|
|||||
Family |
Nucleosome assembly protein (NAP) family
|
|||||
Gene Name |
SET
|
|||||
Organism |
Homo sapiens (Human)
|
|||||
Function |
Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone chaperoning. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher.
|
|||||
UniProt ID | ||||||
UniProt Entry | ||||||
PFam | ||||||
Gene ID | ||||||
Sequence |
MAPKRQSPLPPQKKKPRPPPALGPEETSASAGLPKKGEKEQQEAIEHIDEVQNEIDRLNE
QASEEILKVEQKYNKLRQPFFQKRSELIAKIPNFWVTTFVNHPQVSALLGEEDEEALHYL TRVEVTEFEDIKSGYRIDFYFDENPYFENKVLSKEFHLNESGDPSSKSTEIKWKSGKDLT KRSSQTQNKASRKRQHEEPESFFTWFTDHSDAGADELGEVIKDDIWPNPLQYYLVPDMDD EEGEGEEDDDDDEEEEGLEDIDEEGDEDEGEEDEDDDEGEEGEEDEGEDD |
|||||
Sequence Length |
290
|
|||||
Synthetic Binding Protein (SBP) Targeting This BTS |
---|
SBP Name | Highest Status | Mechanism | Affinity | Application | Details | Ref |
---|---|---|---|---|---|---|
Cyclotide anti-SET MCOG1 | Research | Antagonist | N.A. | Chronic myeloid leukaemia [ICD-11: 2B33.2]; Acute myeloid leukaemia [ICD-11: XH8AA5]; B-cell non-hodgkin lymphoma [ICD-11: 2B33.5] | [1] | |
Cyclotide anti-SET MCOG2 | Research | Antagonist | N.A. | Chronic myeloid leukaemia [ICD-11: 2B33.2]; Acute myeloid leukaemia [ICD-11: XH8AA5]; B-cell non-hodgkin lymphoma [ICD-11: 2B33.5] | [1] | |